BioSpace News Archive

Bio NC

Helix and Cone Health Launch Population Genomics Initiative

The hope has always been that genetic testing can lead to not only better health care but also to preventing many health problems in the first place.

November 7, 2023
·
4 min read
BioCapital

World’s First Dual-Chamber Leadless Pacemaker Now Available for Patients with Abnormally Slow Heart Rhythm

MedStar Washington Hospital Center is one of a select few institutions nationwide now offering patients with abnormally slow heart rates breakthrough technology that delivers treatment by a revolutionary new technology: two tiny leadless pacemakers implanted within the heart.

November 7, 2023
·
3 min read
Business

Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update

Pyxis Oncology, Inc. (Nasdaq: PYXS) today announced initiatives to extend its cash runway, reported financial results for the quarter ended September 30, 2023, and provided a corporate update.

November 7, 2023
·
10 min read
Business

Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business

Teva Pharmaceutical Industries Ltd. announced the appointment of Dr. R. Ananthanarayanan as CEO of its Teva Active Pharmaceutical Ingredients business.

November 7, 2023
·
5 min read
Business

Theravance Biopharma, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update

Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced financial and operational results for the third quarter of 2023.

November 7, 2023
·
23 min read
Biotech Bay

Ultragenyx to Participate in the 2023 Jefferies London Healthcare Conference

Ultragenyx Pharmaceutical Inc. announced that Emil D. Kakkis, M.D., Ph.D., the company’s chief executive officer and president, will participate in a fireside chat at the upcoming Jefferies London Healthcare Conference on Tuesday, November 14, 2023, at 12:30 p.m. GMT.

November 7, 2023
·
1 min read
Business

Masimo Announces New Member of the Board of Directors

Masimo announced that Rolf A. Classon has been appointed to Masimo’s Board of Directors.

November 7, 2023
·
7 min read
Antengene to Host 2023 R&D Day and Discuss Key Data with KOLs

Antengene Corporation Limited announced that it will host its 2023 R&D Day on November 17, 2023, to update the medical and investor communities on the company’s progress with its R&D programs.

November 7, 2023
·
6 min read
FDA

Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension

Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise™ Ultrasound Renal Denervation (RDN) system for the treatment of hypertension.

November 7, 2023
·
5 min read
Business

Amneal Reports Third Quarter 2023 Financial Results

Amneal Pharmaceuticals, Inc. announced its results for the third quarter ended September 30, 2023.

November 7, 2023
·
30 min read